Swixx Biopharma Acquires Biopas to Enter Latin America
June, 2024 - Switzerland
28 June 2024 –Swixx Biopharma AG, a global commercial platform dedicated to unlocking access to innovative medicines worldwide, completed the acquisition of Pharma Consulting Group S.A. and its subsidiary Laboratorios Biopas SA (Biopas) as strategic expansion into Latin America. Biopas is a leading pharmaceutical company in Latin America, specializing in the in-licensing, marketing, and sale of pharmaceutical products. With operational headquarters in Bogota, Colombia, Biopas is one of Latin America’s leading independent marketing and distribution companies for international biopharmaceutical firms. Biopas has a presence in 20 countries, including Latin America’s “Top 5“ markets of Argentina, Brazil, Chile, Colombia & Mexico. Biopas leadership team remains at the helm of the combined company in Latin America.
Walder Wyss acted as lead legal advisor for Swixx. Walder Wyss was supported by the law firms CUATRECASAS and Arias Fábrega & Fábrega (ARIFA) in Latin America.
The Walder Wyss team was led byMarkus Vischer(Partner, Corporate/M&A) andSamuel Lieberherr(Counsel, Corporate/M&A) and further includedAngela Diener(Managing Associate, Corporate/M&A),Viviana Montorfano(Trainee, Corporate/M&A) ,Stefan Walder(Counsel, Corporate/M&A),Nico Bernhard(Managing Associate, Corporate/M&A),Iliana Djagova(Counsel, Corporate/M&A),Fabian Akeret(Associate, Corporate/M&A),Roger Ammann(Partner, Banking & Finance),Valentin Wiesner(Managing Associate, Banking & Finance) andThomas Meister(Partner, Tax).
